Approval · Notice of Compliance 37129 · 2026
ADSTILADRIN: Notice of Compliance 37129
Issued March 16, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37129
- Date
- March 16, 2026
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADSTILADRIN | 02566680 | Approved |
Medicinal ingredients
- NADOFARAGENE FIRADENOVEC 75 ML per VIAL